220 related articles for article (PubMed ID: 34754108)
1. Gene-drug pairings for antidepressants and antipsychotics: level of evidence and clinical application.
Murphy LE; Fonseka TM; Bousman CA; Müller DJ
Mol Psychiatry; 2022 Jan; 27(1):593-605. PubMed ID: 34754108
[TBL] [Abstract][Full Text] [Related]
2. Antidepressant prescribing in the precision medicine era: a prescriber's primer on pharmacogenetic tools.
Bousman CA; Forbes M; Jayaram M; Eyre H; Reynolds CF; Berk M; Hopwood M; Ng C
BMC Psychiatry; 2017 Feb; 17(1):60. PubMed ID: 28178974
[TBL] [Abstract][Full Text] [Related]
3. Clinical implementation of preemptive pharmacogenomics in psychiatry: Τhe "PREPARE" study.
Tsermpini EE; Skokou M; Ferentinos P; Georgila E; Gourzis P; Assimakopoulos K; Patrinos GP;
Psychiatriki; 2020; 31(4):341-351. PubMed ID: 33361064
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics in Child and Adolescent Psychiatry: Background and Evidence-Based Clinical Applications.
Malik S; Verma P; Ruaño G; Al Siaghy A; Dilawar A; Bishop JR; Strawn JR; Namerow LB
J Child Adolesc Psychopharmacol; 2024 Feb; 34(1):4-20. PubMed ID: 38377525
[TBL] [Abstract][Full Text] [Related]
5. Delineating significant genome-wide associations of variants with antipsychotic and antidepressant treatment response: implications for clinical pharmacogenomics.
Koromina M; Koutsilieri S; Patrinos GP
Hum Genomics; 2020 Jan; 14(1):4. PubMed ID: 31941550
[TBL] [Abstract][Full Text] [Related]
6. Discrepancies and similarities in the genome-informed guidance for psychiatric disorders amongst different regulatory bodies and research consortia using next generation sequencing-based clinical pharmacogenomics data.
Kordou Z; Skokou M; Tsermpini EE; Chantratita W; Fukunaga K; Mushiroda T; Patrinos GP; Koromina M
Pharmacol Res; 2021 May; 167():105538. PubMed ID: 33705851
[TBL] [Abstract][Full Text] [Related]
7. A Comparison of Pediatric and Adult Safety Studies for Antipsychotic and Antidepressant Drugs Submitted to the United States Food and Drug Administration.
Liu XI; Schuette P; Burckart GJ; Green DJ; La J; Burnham JM; Rakhmanina N; Robb A; Huang SM; van den Anker JN
J Pediatr; 2019 May; 208():236-242.e3. PubMed ID: 30679050
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research.
Arranz MJ; de Leon J
Mol Psychiatry; 2007 Aug; 12(8):707-47. PubMed ID: 17549063
[TBL] [Abstract][Full Text] [Related]
9. Precision Medicine in Antidepressants Treatment.
Tsermpini EE; Serretti A; Dolžan V
Handb Exp Pharmacol; 2023; 280():131-186. PubMed ID: 37195310
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics of antipsychotics: Clinical utility and implementation.
Arranz MJ; Salazar J; Hernández MH
Behav Brain Res; 2021 Mar; 401():113058. PubMed ID: 33316324
[TBL] [Abstract][Full Text] [Related]
11. [Antidepressant and antipsychotic drug prescribing in Lombardy].
Percudani M; Barbui C; Fortino I; Tansella M; Petrovich L
Epidemiol Psichiatr Soc; 2006; 15(1):59-70. PubMed ID: 16584104
[TBL] [Abstract][Full Text] [Related]
12. Genetic testing for CYP2D6 and CYP2C19 suggests improved outcome for antidepressant and antipsychotic medication.
Walden LM; Brandl EJ; Tiwari AK; Cheema S; Freeman N; Braganza N; Kennedy JL; Müller DJ
Psychiatry Res; 2019 Sep; 279():111-115. PubMed ID: 29699889
[TBL] [Abstract][Full Text] [Related]
13. Benefits of and Barriers to Pharmacogenomics-Guided Treatment for Major Depressive Disorder.
Ahmed AT; Weinshilboum R; Frye MA
Clin Pharmacol Ther; 2018 May; 103(5):767-769. PubMed ID: 29388201
[TBL] [Abstract][Full Text] [Related]
14. Using antipsychotic agents in older patients.
Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
[TBL] [Abstract][Full Text] [Related]
15. Oral health impacts of medications used to treat mental illness.
Cockburn N; Pradhan A; Taing MW; Kisely S; Ford PJ
J Affect Disord; 2017 Dec; 223():184-193. PubMed ID: 28759866
[TBL] [Abstract][Full Text] [Related]
16. Antidepressant pharmacogenetics in children and young adults: A systematic review.
Maruf AA; Greenslade A; Arnold PD; Bousman C
J Affect Disord; 2019 Jul; 254():98-108. PubMed ID: 31112844
[TBL] [Abstract][Full Text] [Related]
17. Clinical Implementation of Pharmacogenetic Decision Support Tools for Antidepressant Drug Prescribing.
Zeier Z; Carpenter LL; Kalin NH; Rodriguez CI; McDonald WM; Widge AS; Nemeroff CB
Am J Psychiatry; 2018 Sep; 175(9):873-886. PubMed ID: 29690793
[TBL] [Abstract][Full Text] [Related]
18. Pharmacogenetic considerations in the elderly patient.
Bright DR; Calinski DM; Kisor DF
Consult Pharm; 2015 Apr; 30(4):228-39. PubMed ID: 25893701
[TBL] [Abstract][Full Text] [Related]
19. Thoughtful Clinical Use of Pharmacogenetics in Child and Adolescent Psychopharmacology.
Ramsey LB; Namerow LB; Bishop JR; Hicks JK; Bousman C; Croarkin PE; Mathews CA; Van Driest SL; Strawn JR
J Am Acad Child Adolesc Psychiatry; 2021 Jun; 60(6):660-664. PubMed ID: 32860906
[TBL] [Abstract][Full Text] [Related]
20. Multi-trajectories of antidepressant and antipsychotic use: a 11-year naturalistic study in a community-based sample.
Verdoux H; Pambrun E; Tournier M; Cortaredona S; Verger P
Acta Psychiatr Scand; 2019 Jun; 139(6):536-547. PubMed ID: 30844084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
